Barrington Research Reiterates Outperform on Merit Medical Systems, Maintains $95 Price Target
Portfolio Pulse from richadhand@benzinga.com
Barrington Research analyst Michael Petusky has reiterated an 'Outperform' rating on Merit Medical Systems (NASDAQ:MMSI) and maintained a $95 price target.
August 16, 2023 | 2:23 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merit Medical Systems (NASDAQ:MMSI) has received an 'Outperform' rating from Barrington Research, with a maintained price target of $95.
The 'Outperform' rating from Barrington Research indicates a positive outlook for Merit Medical Systems. The maintained price target of $95 suggests that the analyst believes the stock has potential for growth. This could positively impact the stock's performance in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100